두시하태독법의 Th2 분화 조절을 통한 알레르기 비염 완화 효과
Reduction of Allergic Rhinitis by Controlling the Th2 Differentiation of Douchi Hataedock
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Objectives: This study investigated the effects of Douchi Hataedock on Th2-skewed conditions to control allergic rhinitis. Methods: NC/Nga mice were divided into three groups: 10 mice were assigned to the control group (CTRL; no treatment), 10 mice to allergic rhinitis-induced (ARE) without treatment group, and 10 mice to the allergic rhinitis-induced (FGT) after Douchi Hataedock treatment group. The 3-week-old mice of the FGT group were given one 10 mg/kg dose of Douchi Hataedock extract and resensitized to allergic antigens at weeks four, five, and six. Allergic rhinitis was induced primarily in mice nasal cavities for five days after one week of final sensitization. The second induction used the same method one week after the first induction was completed. After one week, the nasal mucosal tissues of each group were observed. Immunohistochemical staining for IL-4, STAT6, CD40, FcεRI, substance P, MMP-9, NF-κB p65, p-IkB, and iNOS in the nasal mucosa was also performed. Results: The FGT group had less respiratory epithelial damage and less mucin secretion in goblet cells than the ARE group and showed a 62% decrease in IL-4, 85% decrease in STAT6, 71% decrease in CD40, 69% decrease in FcɛRI, 43% decrease in substance P, 49% decrease in MMP-9, 43% decrease in NF-kB p65, 38% decrease in p-IkB, and 73% decrease in iNOS compared to the ARE group. Conclusions: Douchi Hataedock lessens inflammation in epithelial and goblet cells and reduces inflammatory mediator secretion in a mouse allergic rhinitis model.
Abstract
Objectives: This study investigated the effects of Douchi Hataedock on Th2-skewed conditions to control allergic rhinitis. Methods: NC/Nga mice were divided into three groups: 10 mice were assigned to the control group (CTRL; no treatment), 10 mice to allergic rhinitis-induced (ARE) without treatment group, and 10 mice to the allergic rhinitis-induced (FGT) after Douchi Hataedock treatment group. The 3-week-old mice of the FGT group were given one 10 mg/kg dose of Douchi Hataedock extract and resensitized to allergic antigens at weeks four, five, and six. Allergic rhinitis was induced primarily in mice nasal cavities for five days after one week of final sensitization. The second induction used the same method one week after the first induction was completed. After one week, the nasal mucosal tissues of each group were observed. Immunohistochemical staining for IL-4, STAT6, CD40, FcεRI, substance P, MMP-9, NF-κB p65, p-IkB, and iNOS in the nasal mucosa was also performed. Results: The FGT group had less respiratory epithelial damage and less mucin secretion in goblet cells than the ARE group and showed a 62% decrease in IL-4, 85% decrease in STAT6, 71% decrease in CD40, 69% decrease in FcɛRI, 43% decrease in substance P, 49% decrease in MMP-9, 43% decrease in NF-kB p65, 38% decrease in p-IkB, and 73% decrease in iNOS compared to the ARE group. Conclusions: Douchi Hataedock lessens inflammation in epithelial and goblet cells and reduces inflammatory mediator secretion in a mouse allergic rhinitis model.
참고문헌 (35)
- 고민정, "소아 알레르기비염 환자의 한방치료 효과에 대한 임상적 연구", 대한한방소아과학회지, 25(3), pp.12~26 (2011), 대한한방소아과학회
- David PS, "Allergic rhinits: definition, epidemiology, pathophysiology, detection, and diagnosis", J Allergy ClinImmunol, 108, pp.2~8 (2001)
- 김지은, "알레르기성 비염의 변증과 평가방법에 대한 고찰", 대한한방소아과학회지, 30(1), pp.32~39 (2016), 대한한방소아과학회
- "Allergic Rhinitis and its Impact on Asthma (ARIA) in collaboration with the World Health Organization, Global Allergy and Asthma European Network (GA2LEN)"[URL]
- 구은진, "알레르기성 비염의 한의학 및 보완대체의학적 치료에 대한 국내 임상 연구 동향", 대한한방소아과학회지, 29(4), pp.77~89 (2015), 대한한방소아과학회
- Jan L. Brożek, "Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision", Journal of Allergy and Clinical Immunology, 140(4), pp.950~958 (2017), Elsevier BV[DOI]
- 김재숙, "소아 알레르기비염의 임상 특징", Allergy Asthma & Respiratory Diseases, 3(2), pp.116~123 (2015), 대한 소아알레르기 호흡기학회
- 우현수, "알레르기성 비염의 韓方치료에 대한 고찰", 대한한의학회지, 27(1), pp.155~164 (2006), 대한한의학회
- 김자혜, "알레르기 비염의 대체의학적 치료에 관한 최근 논문경향 분석 - Entrez Pubmed 위주", 한방안이비인후피부과학회지, 20(1), pp.239~249 (2007), 대한한방안이비인후피부과학회
- Leung DY, "Atopic dermatitis: new insights and opportunities for therapeutic intervention", J Allergy Clin Immunol, 105(5), pp.860~876 (2000)
- Mosmann TR, "Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins", J Immunol, 136(7), pp.2348~2357 (1986)
- Saini V, "Cytokines in recurrent pregnancy loss", Clinica Chimica Acta, 412(9-10), pp.702~708 (2011)
- Son JH, "Effects of Pal- Mul-Tang on Cytokines Production from Immune cells during the late stage of Pregnancy in BALB", c, 2000, pp.13(1), 342~375
- Jung AR, "Douchi (Glycine Semen Preparatum) alleviates atopic dermatitis-like skin lesions in NC", Nga mice by regulation of PKC and Th2 cytokines, 2016, pp.16, 416~
- 엄선호, "豆豉 추출물을 이용한 下胎毒法이 NC", Nga 생쥐에서 유발된 아토피 유도 피부염에 미치는 항염증 효과, 2016, pp.30(2), 1~9[DOI]
- 안상현, "두시 하태독법의 IL-4 활성 조절이 D. farinae 유도 아토피유사피부염 발병 조절에 미치는 효과", 대한한방소아과학회지, 31(1), pp.43~51 (2017), 대한한방소아과학회
- Kim JW, "Atopic dermatitis form allergy and immunological perspective", Kor J dermatology, 41(6), pp.687~689 (2003)
- 박용민, "아토피피부염 병태생리에 대한 최신 지견", Allergy Asthma & Respiratory Diseases, 16(3), pp.189~196 (2006), 대한 소아알레르기 호흡기학회
- Romagnani S, "Regulation of the development of type 2 T-helper cells in allergy", Curr Opin Immunol, 6(6), pp.838~846 (1994)
- Kidd P, "Th1", Th2 balance: the hypothesis, its limitations, and implications for health and disease, 2003, pp.8(3), 223~246
- Romagnani S, "T-cell subsets (Th1 versus Th2)", Ann Allergy Asthma Immunol, 85(1), pp.9~21 (2000)
- Akdis M, "IgE class switching and cellular memory", Nat Immunol, 13(4), pp.312~314 (2012)
- Leek JP, "Assignment of the STAT6 gene (STAT6) to human chromosome band 12q13 by in situ hybridization", Cytogenetics and Cell Genetics, 79(3-4), pp.208~209 (1997)
- Hou J, "An interleukin-4-induced transcription factor: IL-4 Stat", Science, 265(5179), pp.1701~1706 (1994)
- Amin K, "The role of mast cells in allergic inflammation", Respir Med, 106(1), pp.9~14 (2012)
- Metcalfe DD, "Mast cells", Physiol Rev, 77(4), pp.1033~1079 (1997)
- Stone KD, "IgE, Mast Cells, Basophils, and Eosinophils", J Allergy Clin Immunol, 125(2 Suppl 2), pp.S73~S80 (2010)
- Park SW, "Substance P is a promoter of adult neural progenitor cell proliferation under normal and ischemic conditions", J Neurosurg, 107(3), pp.593~599 (2007)
- Donkin JJ, "Substance P in traumatic brain injury", Prog Brain Res, 161, pp.97~109 (2007)
- Ebner K, "The role of substance P in stress and anxiety responses", Amino Acids, 31(3), pp.251~272 (2006)
- Yamaoka J, "Rapid changes in substance P signaling and neutral endopeptidase induced by skin-scratching stimulation in mice", J Dermatol Sci, 48(2), pp.123~132 (2007)
- Woessner JF Jr, "MMPs and TIMPs-an historical perspective", Mol Biotechnol, 22(1), pp.33~49 (2002)
- Burrage PS, "Matrix metalloproteinases ; role in arthritis", Front Biosci, 11, pp.529~543 (2006)
- Onodera S, "Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblast of rheumatoid arthritis", J Biol Chem, 275(1), pp.444~450 (2000)
- Baeuerle PA, "NF-κB - Ten years after", Cell, 87, pp.13~20 (1996)
